EXACT SCIENCES (EXK MU) stock market data APIs
€86.311
-0.08(-0.1%)
as of January 2, 2026
Try our APIs with
free plan!
EXACT SCIENCES Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for EXK.MU.
Prev. Close
86.311
Open
86.2317
High
86.4661
Low
86.2122
52 wk Range
33.805-87.61
Market Cap
12 100 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EXACT SCIENCES data using free add-ons & libraries
Get EXACT SCIENCES Fundamental Data
EXACT SCIENCES Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EXACT SCIENCES News
New
3 Unpopular Stocks We Steer Clear Of
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps ...
Should You Continue to Hold EXAS Stock in Your Portfolio Now?
Exact Sciences Corporation EXAS is well-poised to grow in the coming quarters, courtesy of its continuous investment in R&D efforts. In addition, EXAS’ commercial capabilities are driving stronger C...
Moderna Stock Sees Healthy Relative Strength Rating
Moderna stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 67 to 73. See if Moderna stock can continue to rebound and clear that threshold. Moderna s...
How The Abbott Takeover Is Rewriting Exact Sciences Story And Valuation
Exact Sciences stock now sits at the center of a tightening deal spread, with our fair value estimate holding steady near $103.67 per share. This closely tracks the proposed $105 takeout price even as...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
